FEBS J 285(16):29442971 Cuadrado A, Pajares M, Benito C, Jimnez-Villegas J, Escoll M, Fernndez-Gins R, Garcia Yage AJ, Lastra D, Manda G, Rojo AI, Dinkova-Kostova AT (2020) Can Activation of NRF2 Be a Strategy against COVID-19
Reportedly, metformin can inhibit the activities of liver Adcy enzymes [10], which include 9 membrane proteins (Adycs 1 to 9) and one soluble protein (Adcy 10) and produce cAMP from ATP at the plasma membrane
Monitor Side Effects : Keep track of any adverse effects and adjust dosage or frequency accordingly
In 2014, a meta-analysis of 83 randomized clinical trials were performed showing that DPP-4 inhibition reduced HbA1c by 0.40.5% (45 mmol/mol) when added to metformin [Figure 8, ( Figure 8 Placebo-Controlled Studies With DPP-4 Inhibition as Add-on to Ongoing Sulfonylurea Therapy The DPP-4 inhibitors were as well-examined when added to on-going sulfonylurea in subjects with type 2 diabetes in 2426 week placebo-controlled studies with a total number of 3,282 subjects [Table 2